Current Market Information

Last Trade Price (LTP) 47.00 Updated Date 15 January, 2026 Change 0.00 % Open Price 47.00 Day's Range 47.00 - 47.00     Total Trade 0 Total Volume 0 Close Price 47.00 Previous Close Price 47.00 Market Capital in BDT (mn) 5752.492

Contact Information

Designation Name Mobile Number Email Chairman Tahmina Begum 02-48317908 chairman@asiaticpharma.com MD Monir Ahmed 02-48317908 monir@asiaticpharma.com CFO Jayanta Kumar Biswas 01937990018 cfo@asiaticpharma.com Company Secretary Mr. Ishtiaq Ahmed 01937-990004 cs@asiaticpharma.com Office Address 42-43, Siddeshwari Circular Road, Treasure Island (5th Floor) Shantinagar, Dhaka-1217. Phone : +8802-48317908 Fax : +8802-48311633 Email : investor@asiaticpharma.com Website : https://asiaticlaboratories.com/ Factory Address 253, Tongi Industrial Area, Tongi, Gazipur-1700, Bangladesh.

Basic Information

Authorized Capital in BDT* (mn) 2,000.00 Paid-up Capital in BDT* (mn) 1,223.93 Face Value 10 Paid up Share 122393455     Market Lot 1 Sector PHARMA & CHEMICALS Market Category A

Other Information

Listing Year 2024 Debut Trade Date 06 March, 2024 Type of Instrument Equity     52 Week's Range 29.50 - 63.10 Year End 30 June Reserve / Surplus(mn) 4633.4 Remarks TK 1,624,138,128 Revaluation Reserve has been added to Reserve & Surplus. Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 31-Dec, 2025 40.71 0 15.65 0 43.64 As on 30-Nov, 2025 40.71 0 16.65 0 42.64 As on 31-Oct, 2025 40.71 0 18.57 0 40.72 As on 30-Jun, 2025 (year ended) 40.71 0 18.09 0 41.2     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Jan 05, 2026 BBB ST-3 Stable Jan 04, 2027 WASO Credit Rating Company(BD) Ltd. Oct 05, 2021 A3 ST-3 Stable Oct 04, 2022 WASO Credit Rating Company(BD) Ltd.         Half Year End (HY) Information  202412 HY Net Turnover(mn)   HY Net Profit after tax(mn)   HY EPS  0.96  AGM Information   AGM Date  24 December, 2025 Record Date  20 November, 2025 Dividend(%)  10.00(Cash dividend for all Shareholders excluding Directors and Sponsors-June 2025) Bonus Issue

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2025	2.09	0	0	0	54.08	0	255.36	0	10%C	2.65
2024	2.82	0	0	0	52.58	0	278.48	0	10%C	2.02
2023	2.19	0	0	0	64.48	0	205.85	0		0
2022	3.06	0	2.19	0	59.68	50.6	268.56	0		0

Financial Statements
Quarterly Financial Statement
Price Sensitive Information

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To